Dry Eye – Can You Cry?
Ocular surface discomfort is often attributed to the symptoms of dry eye, but conditions affecting the lacrimal gland are uncommon. Meibomian gland dysfunction (MGD) is extremely common and is a characteristic feature of many patients with dry eye symptoms. Most ophthalmologists choose some type of lubricant artificial tear drop as first-line treatment for dry eye symptoms, but this paper questions the rationale for this decision. Patients who can cry, or produce tears from any stimulus, demonstrate lacrimal gland function. This paper considers the rationale for employing a safe, effective, biodegradable warm compress as first-line treatment for MGD and associated dry eye symptoms.
Dry eye, meibomian gland dysfunction, Sjögren syndrome, blepharitis, warm compress, EyeBag®, anthropocene
Compliance with Ethics: This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors. All images published with full patient consent and permissions. All photographs taken by the author.
Double-blind peer review.
The named authors meets the International
Committee of Medical Journal Editors (ICMJE) criteria
for authorship of this manuscript, takes responsibility
for the integrity of the work as a whole, and has given
final approval for the version to be published.
Teifi James, The EyeBag Company, Unit 5, Calderdale Business Park, Club Lane. Halifax, West Yorkshire, HX2 8DB, UK. E: firstname.lastname@example.org
No funding was received for the publication of this article.
18 November 2019
Share this Article
Related Content In Ocular Surface Disease
Reproxalap for the Treatment of Dry Eye Disease
touchREVIEWS in Ophthalmology. 2023;17(1):31–5 DOI: https://doi.org/10.17925/USOR.2023.17.1.31
Reproxalap is a reactive aldehyde species (RASP) inhibitor believed to mitigate inflammatory conditions such as dry eye disease (DED), allergic conjunctivitis and uveitis.1 RASP are pro-inflammatory molecules that covalently bind to thiol and amino groups expressed on various receptors and kinases. This binding activates the pro-inflammatory signalling cascade, which involves the activation of inflammatory cytokines leading to inflammation and pro–histaminic factors leading to an allergic response.1 Malondialdehyde (MDA) […]
Novel Molecule Lotilaner Could Potentially Offer Relief to Long-suffering Demodex Blepharitis Patients
touchREVIEWS in Ophthalmology 2022;16(1):2–5 DOI: https://doi.org/10.17925/USOR.2022.16.1.2
Demodex blepharitis is a highly prevalent lid margin disease that is commonly missed or misdiagnosed by eye care professionals. The disease is caused by an infestation of Demodex mites – tiny parasites that live in the eyelash follicles and feed on oily sebum. When present in small numbers, the effects of these mites are subclinical and are likely […]
The Impact of Continuous Positive Airway Pressure Use on Dry Eye Disease
touchREVIEWS in Ophthalmology. 2021;16(1):40–1 DOI: https://doi.org/10.17925/USOR.2022.16.1.40
The prevalence of both dry eye disease and sleep apnoea has steadily increased in the USA.1 Importantly, new research reveals the need for multispecialty collaboration based on evidence that patients may be at risk for eye irritation secondary to airflow from mask leakage or retrograde nasolacrimal air escape.2 Sleep apnoea and ocular disorders Sleep apnoea is […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!